 Connection
Alyssa Schlenz to Mass Screening
This is a "connection" page, showing publications Alyssa Schlenz has written about Mass Screening.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.253 |
|
|
|
-
Schlenz AM, Phillips SM, Mueller M, Humphrey D, Stevens J, Williams LP, Nickel RS, Dolatshahi L, Miller RE, Hulbert ML, Lee MT, Alvarez O, Fuh B, McNaull MA, Bhasin N, Melvin CL, Adams RJ, Kanter J. Successful implementation of stroke risk screening for sickle cell anemia in the DISPLACE study: results of a cluster randomized trial. Implement Sci. 2025 11 26; 20(1):50.
Score: 0.502
-
Schlenz AM, Phillips SM, Stevens J, Williams LP, Lee MT, Nickel R, Fuh B, Dolatshahi L, Kanter J. Lessons Learned From Provider Minder: A Provider Tracking Application for Improving Stroke Risk Screening in Sickle Cell Anemia. Qual Manag Health Care. 2026 Apr-Jun 01; 35(2):110-118.
Score: 0.495
-
Kanter J, Phillips S, Schlenz AM, Mueller M, Dooley M, Sirline L, Nickel R, Brown RC, Hilliard L, Melvin CL, Adams RJ. Transcranial Doppler Screening in a Current Cohort of Children With Sickle Cell Anemia: Results From the DISPLACE Study. J Pediatr Hematol Oncol. 2021 11 01; 43(8):e1062-e1068.
Score: 0.095
-
Phillips S, Schlenz AM, Mueller M, Melvin C, Adams RJ, Kanter J. Practice patterns for neuroimaging and transfusion therapy for management of neurologic complications in sickle cell anemia: DISPLACE consortium. Pediatr Blood Cancer. 2020 11; 67(11):e28569.
Score: 0.087
-
Schatz J, Schlenz AM, Smith KE, Roberts CW. Predictive validity of developmental screening in young children with sickle cell disease: a longitudinal follow-up study. Dev Med Child Neurol. 2018 05; 60(5):520-526.
Score: 0.073
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|